Share
Services
Fresenius Helios has opened the new building at its hospital in the western German city of Duisburg. The 22,000-square-meter (237,000-square-foot) structure will accommodate up to 350 inpatients. Construction took two years, with Fresenius Helios investing €50 million in the new building. The move from the existing facility into the new building will start later this month.
Quirónsalud, a unit of Fresenius Helios, is investing about €40 million to build a proton beam therapy center in Madrid. Scheduled for opening in 2019, it will be the first facility of this type for treating cancer patients in Spain. Currently, every patient who can benefit from proton beam therapy must seek treatment outside the country. In proton beam therapy, the use of a high-energy beam allows tumors to be irradiated with lower total doses of radiation and reduced exposure to surrounding tissue compared with conventional radiation therapy. Quirónsalud will also modernize and expand its radiotherapy clinics in Palmaplanas (Mallorca) and Seville.
Quirónsalud, a unit of Fresenius Helios, is investing about €40 million to build a proton beam therapy center in Madrid. Scheduled for opening in 2019, it will be the first facility of this type for treating cancer patients in Spain. Currently, every patient who can benefit from proton beam therapy must seek treatment outside the country. In proton beam therapy, the use of a high-energy beam allows tumors to be irradiated with lower total doses of radiation and reduced exposure to surrounding tissue compared with conventional radiation therapy. Quirónsalud will also modernize and expand its radiotherapy clinics in Palmaplanas (Mallorca) and Seville.
Quirónsalud is Spain’s largest hospital operator. Shown here is the Hospital Universitario Quirónsalud Madrid.
Fresenius Helios closed its €5.76 billion acquisition of IDC Salud Holding S.L.U. (”Quirónsalud”) today, as planned. Quirónsalud will be consolidated as of February 1, 2017.
Of the total purchase price for Spain’s largest private hospital operator, €5.36 billion had already been debt-financed. The balance of €400 million was paid in the form of 6,108,176 new Fresenius shares issued today from authorized capital excluding subscription rights.
Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and about 300 Occupational Risk Prevention centers located in all economically important areas of Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius Helios closed its €5.76 billion acquisition of IDC Salud Holding S.L.U. (”Quirónsalud”) today, as planned. Quirónsalud will be consolidated as of February 1, 2017.
Of the total purchase price for Spain’s largest private hospital operator, €5.36 billion had already been debt-financed. The balance of €400 million was paid in the form of 6,108,176 new Fresenius shares issued today from authorized capital excluding subscription rights.
Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and about 300 Occupational Risk Prevention centers located in all economically important areas of Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius Helios today received antitrust approval to acquire Quirónsalud, Spain’s largest private hospital operator. The relevant Spanish antitrust authority has approved the transaction without imposing conditions. The acquisition can therefore be closed by January 31, 2017. Quirónsalud will be consolidated as of February 1, 2017.
Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and around 300 Occupational Risk Prevention (“ORP”) centers located in all economically important areas in Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.
Given the expected meaningful accretion to Group sales and earnings, Fresenius will publish new mid-term targets as part of its full-year 2016 reporting.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius Helios today received antitrust approval to acquire Quirónsalud, Spain’s largest private hospital operator. The relevant Spanish antitrust authority has approved the transaction without imposing conditions. The acquisition can therefore be closed by January 31, 2017. Quirónsalud will be consolidated as of February 1, 2017.
Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and around 300 Occupational Risk Prevention (“ORP”) centers located in all economically important areas in Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.
Given the expected meaningful accretion to Group sales and earnings, Fresenius will publish new mid-term targets as part of its full-year 2016 reporting.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius Helios has laid the foundation stone for a new main building at HELIOS Hospital Dr. Horst Schmidt Kliniken in the German city of Wiesbaden, near Frankfurt. The seven-story structure, with 96,000 square meters (about 1 million square feet) of floor space, is being erected beside the existing clinic. It will have 22 operating rooms, more than 900 beds, and a design that significantly reduces distances and waiting times for patients. HELIOS is investing about €200 million in the new building, while the state of Hesse is contributing €68 million. Completion is scheduled for 2020.
Fresenius Helios has laid the foundation stone for a new main building at HELIOS Hospital Dr. Horst Schmidt Kliniken in the German city of Wiesbaden, near Frankfurt. The seven-story structure, with 96,000 square meters (about 1 million square feet) of floor space, is being erected beside the existing clinic. It will have 22 operating rooms, more than 900 beds, and a design that significantly reduces distances and waiting times for patients. HELIOS is investing about €200 million in the new building, while the state of Hesse is contributing €68 million. Completion is scheduled for 2020.
